Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

240 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prevalence of Renal Insufficiency in cancer patients and implications for anticancer drug management: the renal insufficiency and anticancer medications (IRMA) study.
Launay-Vacher V, Oudard S, Janus N, Gligorov J, Pourrat X, Rixe O, Morere JF, Beuzeboc P, Deray G; Renal Insufficiency and Cancer Medications (IRMA) Study Group. Launay-Vacher V, et al. Among authors: gligorov j. Cancer. 2007 Sep 15;110(6):1376-84. doi: 10.1002/cncr.22904. Cancer. 2007. PMID: 17634949 Free article.
Prevalence of renal insufficiency in breast cancer patients and related pharmacological issues.
Launay-Vacher V, Gligorov J, Le Tourneau C, Janus N, Spano JP, Ray-Coquard I, Oudard S, Pourrat X, Morere JF, Deray G, Beuzeboc P; Renal Insufficiency and Anticancer Medications (IRMA) Study Group. Launay-Vacher V, et al. Among authors: gligorov j. Breast Cancer Res Treat. 2010 Dec;124(3):745-53. doi: 10.1007/s10549-008-0131-1. Epub 2008 Aug 15. Breast Cancer Res Treat. 2010. PMID: 18704681
Lung cancer and renal insufficiency: prevalence and anticancer drug issues.
Launay-Vacher V, Etessami R, Janus N, Spano JP, Ray-Coquard I, Oudard S, Gligorov J, Pourrat X, Beuzeboc P, Deray G, Morere JF; Renal Insufficiency Anticancer Medications (IRMA) Study Group. Launay-Vacher V, et al. Among authors: gligorov j. Lung. 2009 Jan-Feb;187(1):69-74. doi: 10.1007/s00408-008-9123-5. Epub 2008 Oct 22. Lung. 2009. PMID: 18941834
Renal insufficiency and anticancer drugs in elderly cancer patients: a subgroup analysis of the IRMA study.
Launay-Vacher V, Spano JP, Janus N, Gligorov J, Ray-Coquard I, Oudard S, Pourrat X, Morere JF, Beuzeboc P, Deray G; Renal Insufficiency and Anticancer Medications (IRMA) Study Group. Launay-Vacher V, et al. Among authors: gligorov j. Crit Rev Oncol Hematol. 2009 May;70(2):124-33. doi: 10.1016/j.critrevonc.2008.09.012. Epub 2008 Nov 5. Crit Rev Oncol Hematol. 2009. PMID: 18990585
Drug management of prostate cancer: prevalence and consequences of renal insufficiency.
Launay-Vacher V, Ayllon J, Janus N, Spano JP, Ray-Coquard I, Gligorov J, Pourrat X, Morere JF, Beuzeboc P, Deray G, Oudard S; Renal Insufficiency and Anticancer Medications (IRMA) Study Group. Launay-Vacher V, et al. Among authors: gligorov j. Clin Genitourin Cancer. 2009 Oct;7(3):E83-9. doi: 10.3816/CGC.2009.n.029. Clin Genitourin Cancer. 2009. PMID: 19815487
[Renal insufficiency and breast cancer].
Beuzeboc P, Le Tourneau C, Gligorov J, Janus N, Spano JP, Ray-Coquard I, Deray G, Launay-Vacher V. Beuzeboc P, et al. Among authors: gligorov j. Bull Cancer. 2012 Mar 1;99(3):309-15. doi: 10.1684/bdc.2011.1478. Bull Cancer. 2012. PMID: 22106161 Free article. French.
Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study's primary analysis of 2573 patients.
Gligorov J, Ataseven B, Verrill M, De Laurentiis M, Jung KH, Azim HA, Al-Sakaff N, Lauer S, Shing M, Pivot X; SafeHer Study Group. Gligorov J, et al. Eur J Cancer. 2017 Sep;82:237-246. doi: 10.1016/j.ejca.2017.05.010. Epub 2017 Jun 16. Eur J Cancer. 2017. PMID: 28625777 Clinical Trial.
Patients' preference of trastuzumab administration (subcutaneous versus intravenous) in HER2-positive metastatic breast cancer: Results of the randomised MetaspHer study.
Pivot X, Spano JP, Espie M, Cottu P, Jouannaud C, Pottier V, Moreau L, Extra JM, Lortholary A, Rivera P, Spaeth D, Attar-Rabia H, Benkanoun C, Dima-Martinez L, Esposito N, Gligorov J. Pivot X, et al. Among authors: gligorov j. Eur J Cancer. 2017 Sep;82:230-236. doi: 10.1016/j.ejca.2017.05.009. Epub 2017 Jun 23. Eur J Cancer. 2017. PMID: 28648618 Clinical Trial.
240 results